Position in SANA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$605,674
+$387,711 QoQ
Shares Held
173,546
+129.3% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 211 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,023 across 417 Biotechnology names. SANA ranks #170 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in SANA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $605,674 | 173,546 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $217,963 | 75,682 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $777,699 | 191,081 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $377,598 | 106,366 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $230,946 | 84,596 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $107,548 | 64,017 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $101,093 | 62,021 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $170,854 | 41,071 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $258,791 | 47,398 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $349,040 | 34,904 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $124,125 | 30,423 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $321,283 | 83,019 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $551,484 | 92,531 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $274,584 | 83,971 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $817 | 207 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $19,044 | 3,174 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $31,892 | 4,960 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $66,046 | 7,996 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $582,310 | 37,617 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $10,787 | 479 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $13,958 | 710 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $7,295 | 218 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||